Christopher Chapman MD - CEO & Chairman, Director at Telomir Pharmaceuticals, Inc.

Issuer-level insider activity

Role
CEO & Chairman, Director
Issuer ticker
TELO on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Christopher Chapman MD since 19 Aug 2025

Reported holdings for Christopher Chapman MD in Telomir Pharmaceuticals, Inc.

Form 4 holding CEO & Chairman, Director

Telomir Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
975,610
Estimated value
$6,048,782
Report date
08 Feb 2024
Price
$6.20
Ownership
Direct

Transaction history for Christopher Chapman MD in Telomir Pharmaceuticals, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .